Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedClinicalTrials.gov updated the page’s display revision label from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision: v3.5.2 added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 across the page. This appears to be a system version bump with no changes to trial details or user interactions.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No user-facing content or functionality appears affected.SummaryDifference0.1%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.